Aspen Pharmacare Generics Company Intelligence Report - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/63392

Aspen Pharmacare Generics Company Intelligence Report

Description:

Aspen is Africa's largest manufacturer of generic drugs, and the leading supplier of generic products to both the private and public sectors in South Africa. Additionally, the company is a major supplier of branded pharmaceutical and healthcare products to the southern African market. The company is listed on the Johannesburg Stock Exchange.

In FY2010, Aspen reported revenues worth R10,146.6 million (US$1,341.7 million), up by 20.2% over the prior year. Net profit rose by 46.2%, reaching R1,978.5 million (US$261.6 million).

Aspen has agreements with companies including Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Roche and GlaxoSmithKline, allowing it to produce generic versions of those companies' antiretrovirals.

In January 2005, the FDA announced it had granted tentative approval for a copackaged antiretroviral drug manufactured by Aspen. The tentative approval allowed the product to be available for procurement under the President's Emergency Plan for AIDS Relief (PEPFAR).

In March 2010, India's Indoco Remedies reported it had licensed out its intellectual property dossiers to Aspen. The deal encompassed a number of ophthalmic products, and would extend to 30 countries from emerging markets.

In May 2010, Aspen made overtures to acquire the pharmaceutical business of Australia's Sigma Pharmaceuticals. In August 2010, the deal entered its final phases, with Sigma agreeing to sell.

Executive Summary

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation.

Contents:

1.Executive Summary 2.Introduction 3.Products 4.Financial Results 5.Major Developments 6.Contact Details

Companies Mentioned

- Roche - Oseltamivir - Saquinavir - Bristol-Myers Squibb - Lupin Laboratories. - Gilead - Matrix Laboratories - Fine Chemicals Corporation - William J Clinton Presidential Foundation - Eli Lilly - GlaxoSmithKline - Strides Arcolab

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/63392

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 12/02/2012 13:16:57

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Aspen Pharmacare Generics Company Intelligence Report
Web Address:
http://www.researchandmarkets.com/reports/63392
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		€245.00
Electronic (Online Access) - Enterprisewide		€1,595.00
Hard Copy		€245.00 + EUR€ 25.00 Shipping/Handling *
Electronic (Online Access) - Single User		€245.00
Electronic (PDF) - Enterprisewide		€1,595.00

* Shipping/Handling is only charged once per order.

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 12/02/2012 13:16:57

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)